Targeting neural circuits in psychiatry
Exploring how circuit-based understandings of psychiatric illness are challenging traditional diagnostic classification and therapeutic specificity
With the development of brain science, modulating neural circuits is increasingly being considered as a treatment for mental and neurological disorders. Brain function can be precisely alleviated or reversed using opto- and chemo-genetic techniques in animals and invasive and non-invasive neuromodulation in humans. Neuromodulation can potentiate behavioural and cognitive interventions and lead to durable neuroplastic changes. Furthermore, recent studies have provided novel insights into the precise regulation of the neural circuit functions by small molecular compounds targeting the enriched molecules or receptors of these neural circuits.
As part of our Precision Psychiatry Roadmap initiative, the ECNP New Frontiers Meeting 2025 will focus on the potential for targeting neurocircuitry in mental disorders, and explore how a circuit-based understanding of psychiatric illness is challenging the traditional diagnostic classification and thus the notion of therapeutic specificity. During the meeting, we will be discussing the role and biological understanding of neurocircuits in mental disorders, emerging technologies in the field to target neurocircuits, and the translation of new knowledge on neurocircuits into therapeutic opportunities for patients.
More info about the ECNP Roadmap Initiative can be found here.
How to attend
Application for in-person participants and registration for virtual participants is open.
Join here
Deadlines
The deadline for the applications for in-person participants is 27 November 2024 at 17.00 CET (Central European Time).
The deadline to register for virtual participation is 19 March 2025 at 23.59 CET (Central European Time).
Support opportunities
If your company or organisation would like to be an official supporter of the meeting, please contact us.
